Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect.
Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.
Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis.
What is Susac syndrome? - A brief review of articles.
Resilience Predicts Functional Outcomes in People Aging with Disability: A Longitudinal Investigation.
Involvement of MeCP2 in Regulation of Myelin-Related Gene Expression in Cultured Rat Oligodendrocytes.
Staying on the job: The relationship between work performance and cognition in individuals diagnosed with multiple sclerosis.
Multiple sclerosis: Does low vitamin D level during pregnancy increase the risk of MS?
Modeling the course and outcomes of MS is statistical twaddle-No.
'The worm that got away': parainfectious atypical optic neuritis associated with schistosomiasis infection.
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain.
Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy.
High-throughput sequencing of immune repertoires in multiple sclerosis.
Erythropoietin Levels in Patients with Multiple SclerosisComplicated with Anemia.
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica.
Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu).
Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.
Whole Transcriptome Screening Reveals Myelination Deficits in Dysplastic Human Temporal Neocortex.
Cytomegalovirus seropositivity is negatively associated with multiple sclerosis.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: Commentary.
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis.
Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
[Oral treatments in multiple sclerosis].
Serum proteomics in multiple sclerosis disease progression.
Pages
« first
‹ previous
…
589
590
591
592
593
594
595
596
597
…
next ›
last »